Scarica l'app Stockscreener
64.49
1.78%
1.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
What PTC Therapeutics (PTCT)'s FDA Leadership Shift Means For Its Gene and RNA Pipeline Narrative - simplywall.st
Matthew Klein Sells 2,662 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics (PTCT) CEO logs RSU vesting and automatic tax share sale - Stock Titan
18 new PTC Therapeutics hires receive stock options, RSUs - Stock Titan
FDA Shift Reframes PTC Therapeutics Regulatory Risks And Reward Profile - Sahm
Insider Sell: Stephanie Okey Sells 15,167 Shares of PTC Therapeu - GuruFocus
Stephanie Okey Sells 15,167 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
B. Metzler seel. Sohn & Co. AG Invests $944,000 in PTC Therapeutics, Inc. $PTCT - MarketBeat
FDA ‘blacklist’ in DMD? Legislator slams PTC turndown - bioworld.com
PTC Therapeutics at Barclays Conference: Sephience’s Global Potential By Investing.com - Investing.com Canada
PTCT: Sepiapterin’s rapid PKU launch drives strong growth, with global expansion and pipeline progress - TradingView
PTCT Earnings History & Surprises | EPS & Revenue Results | PTC THERAPEUTICS INC (NASDAQ:PTCT) - ChartMill
PTC Therapeutics Stock Soars 8.88%, Hits Intraday High of $69.17 - Markets Mojo
PTC Therapeutics at Leerink Conference: Strategic Growth in PKU Market By Investing.com - Investing.com Canada
PTC Therapeutics (+8.9%): FDA Leadership Change Spurs Sector-Wide Rally - Trefis
(PTCT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Lee Scott Golden Sells 10,000 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Neil Gregory Almstead Sells 3,989 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Executive stock sale by PTC Therapeutics (PTCT) Chief Medical Officer - Stock Titan
PTC Therapeutics (PTCT) CTO spouse sells shares under 10b5-1 trading plan - Stock Titan
PTC Therapeutics (NASDAQ:PTCT) Shares Up 6.9%Time to Buy? - MarketBeat
Jefferies Financial Group Acquires Stake in PTC Therapeutics - National Today
Jefferies Financial Group Inc. Acquires Shares of 1,584,678 PTC Therapeutics, Inc. $PTCT - MarketBeat
Ideas Watch: Will PTC Therapeutics Inc. benefit from government policy2026 Setups & Safe Entry Trade Signal Reports - baoquankhu1.vn
Dividend Watch: Is PTC Therapeutics Inc a stock for growth or value investorsMarket Volume Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Royce & Associates LP Has $2.01 Million Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
Neil G. Almstead sells multiple PTCT lots (PTCT) — Form 144 details - Stock Titan
PTC Therapeutics, Inc. (PTCT) - DirectorsTalk Interviews
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing - Yahoo Finance
Oversold Conditions For PTC Therapeutics (PTCT) - Nasdaq
PTC Therapeutics (PTCT) Gains Edge as Competitor Faces Setback - GuruFocus
PTC Therapeutics Grants Stock Options and RSUs to New Employees - Intellectia AI
Assessing PTC Therapeutics (PTCT) Valuation After Contrasting Quarterly Loss And Full Year Profit Turnaround - Sahm
JPMorgan Chase & Co. Reduces Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics vs Merck: Which Is the Stronger Buy Today? - Trefis
GSA Capital Partners LLP Decreases Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
16,062 Shares in PTC Therapeutics, Inc. $PTCT Purchased by Private Capital Advisors Inc. - MarketBeat
PTC Therapeutics, Inc. $PTCT Holdings Decreased by Vanguard Group Inc. - MarketBeat
PTC Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 earnings call transcript - MSN
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 Earnings Call Transcript - Insider Monkey
PTC Therapeutics outlines 19%-36% 2026 product revenue growth target as Sephience momentum accelerates globally - MSN
How Translarna NDA Withdrawal and Mixed Results Will Impact PTC Therapeutics (PTCT) Investors - Sahm
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 24.21% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 3,019 Shares of Stock - MarketBeat
PTC Therapeutics (PTCT) CLO Boulding sells 3,019 shares under 10b5-1 plan - Stock Titan
PTC Therapeutics to Participate at Upcoming Investor Conferences - GuruFocus
Morgan Stanley raises PTC Therapeutics stock price target on OpEx cuts - Investing.com Australia
PTC Therapeutics: Sephience As A Major Growth Driver (NASDAQ:PTCT) - Seeking Alpha
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations - Yahoo Finance
PTC Therapeutics, Inc. $PTCT Shares Sold by Hillsdale Investment Management Inc. - MarketBeat
19,142 Shares in PTC Therapeutics, Inc. $PTCT Acquired by Brummer Multi Strategy AB - MarketBeat
PTC Therapeutics (PTCT) Q4 earnings: Taking a look at key metrics versus estimates - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), Guardant Health (GH) and PTC Therapeutics (PTCT) - The Globe and Mail
PTC Therapeutics (NASDAQ:PTCT) Cut to "Hold" at Wall Street Zen - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CAO Sells 2,494 Shares of Stock - MarketBeat
Lee Scott Golden Sells 2,484 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 3,019 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 3,056 Shares - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CFO Pierre Gravier Sells 2,992 Shares - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CEO Sells 7,371 Shares of Stock - MarketBeat
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):